These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 6893175

  • 1. Biologic and therapeutic effects of 1 alpha-hydroxycholecalciferol in different types of Fanconi syndrome.
    Kitagawa T, Akatsuka A, Owada M, Mano T.
    Contrib Nephrol; 1980; 22():107-19. PubMed ID: 6893175
    [Abstract] [Full Text] [Related]

  • 2. The effects of calciferol and its metabolites on patients with chronic renal failure. II. Calcitriol, 1 alpha-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3.
    Voigts AL, Felsenfeld AJ, Llach F.
    Arch Intern Med; 1983 Jun; 143(6):1205-11. PubMed ID: 6344827
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D and vitamin D dependency.
    Tsuchiya Y, Matsuo N, Cho H, Tsubouchi K, Kumagai M, Nishii Y, Nanjoh M, Yamamoto T.
    Contrib Nephrol; 1980 Jun; 22():89-100. PubMed ID: 6967387
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets.
    Delvin EE, Glorieux FH.
    Calcif Tissue Int; 1981 Jun; 33(2):173-5. PubMed ID: 6260313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A, Bordier P, Gueris J, Sebert JL, Marie P, Ferrière C, Bedrossian J, DeLuca HF.
    Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
    [No Abstract] [Full Text] [Related]

  • 9. A case of pseudovitamin D deficiency-like rickets in an infant treated with 1,25-dihydroxycholecalciferol. Preliminary note.
    Vecchio F, Carnevale F, Paganetti G, di Bitonto G, Marinelli G.
    J Inherit Metab Dis; 1978 Feb; 1(4):183-5. PubMed ID: 117256
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of renal bone disease with 1 alpha-hydroxylated derivatives of vitamin D3. Clinical, biochemical, radiographic and histological responses.
    Kanis JA, Cundy T, Earnshaw M, Henderson RG, Heynen G, Naik R, Russell RG, Smith R, Woods CG.
    Q J Med; 1979 Apr; 48(190):289-322. PubMed ID: 504552
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evidence that different vitamin D sterols have qualitatively different effects in man.
    Rasmussen H, Bordier P.
    Contrib Nephrol; 1980 Apr; 18():184-91. PubMed ID: 7353375
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 14. Influence of long-term oral 1,25-dihydroxyvitamin D in childhood renal osteodystrophy.
    Chesney RW, Hamstra A, Jax DK, Mazess RB, DeLuca HF.
    Contrib Nephrol; 1980 Nov; 18():55-71. PubMed ID: 7353380
    [No Abstract] [Full Text] [Related]

  • 15. Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol.
    Chan JC, DeLuca HR.
    JAMA; 1979 Mar 23; 241(12):1242-4. PubMed ID: 762789
    [Abstract] [Full Text] [Related]

  • 16. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC, Lovinger RD, Mamunes P.
    Pediatrics; 1980 Sep 23; 66(3):445-54. PubMed ID: 6893489
    [Abstract] [Full Text] [Related]

  • 17. Infantile rickets with server proximal renal tubular acidosis, responsive to vitamin D.
    Huguenin M, Schacht R, David R.
    Arch Dis Child; 1974 Dec 23; 49(12):955-9. PubMed ID: 4374899
    [Abstract] [Full Text] [Related]

  • 18. Influence of phosphate depletion on the biosynthesis and circulating level of 1alpha,25-dihydroxyvitamin D.
    Haussler M, Hughes M, Baylink D, Littledike ET, Cork D, Pitt M.
    Adv Exp Med Biol; 1977 Dec 23; 81():233-50. PubMed ID: 899927
    [No Abstract] [Full Text] [Related]

  • 19. [Determination of metabolites of vitamin D in a case of Debré-De Toni-Fanconi syndrome secondary to cystinosis].
    Ottolenghi A, Colussi G, De Chiara A, Gerosa R, Gasparro C, Colacicco B.
    Pediatr Med Chir; 1986 Dec 23; 8(2):287-90. PubMed ID: 3491362
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y, Shimotsuji T, Ishii T, Ishida M, Ikehara C, Yamaoka K, Yabuuchi H, Dokoh S.
    Arch Dis Child; 1980 Jan 23; 55(1):49-53. PubMed ID: 6246841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.